Identification of CD34+ and CD34− leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia

Author:

Aoki Yuki12,Watanabe Takashi3,Saito Yoriko1,Kuroki Yoko3,Hijikata Atsushi3,Takagi Masatoshi2,Tomizawa Daisuke4,Eguchi Mariko5,Eguchi-Ishimae Minenori5,Kaneko Akiko1,Ono Rintaro1,Sato Kaori1,Suzuki Nahoko1,Fujiki Saera1,Koh Katsuyoshi6,Ishii Eiichi5,Shultz Leonard D.7,Ohara Osamu38,Mizutani Shuki2,Ishikawa Fumihiko1

Affiliation:

1. Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;

2. Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan;

3. Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;

4. Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan;

5. Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan;

6. Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan;

7. The Jackson Laboratory, Bar Harbor, ME; and

8. Kazusa DNA Research Institute, Kisarazu, Chiba, Japan

Abstract

Key Points Using an in vivo model for primary MLL-rearranged infant ALL, we identified phenotypically and functionally distinct LICs and HSCs. In MLL ALL patient samples, molecules differentially expressed between LICs and HSCs including CD9, CD32, and CD24 were identified.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3